libaiyi
★    

China,
2019-04-09 09:15
(1841 d 01:26 ago)

Posting: # 20134
Views: 3,059
 

 Tmax in three treatment, three period, three sequence design [Nonparametrics]

Dear all,

I have a question about Wilcoxon signed rank test on Tmax. In a three treatment, three period, three sequece design (two test formulations and one reference formulation with the sequences as T1-R-T2, R-T2-T1, and T2-T1-R), can we use Wilcoxon signed rank test for Tmax? If not, what can we do to statistically evaluate Tmax?

Thanks in advance!

Best,

Libaiyi
jag009
★★★

NJ,
2019-04-12 20:19
(1837 d 14:21 ago)

@ libaiyi
Posting: # 20154
Views: 2,433
 

 Tmax in three treatment, three period, three sequence design

Hi,

❝ I have a question about Wilcoxon signed rank test on Tmax. In a three treatment, three period, three sequece design (two test formulations and one reference formulation with the sequences as T1-R-T2, R-T2-T1, and T2-T1-R), can we use Wilcoxon signed rank test for Tmax? If not, what can we do to statistically evaluate Tmax?


Yes there are other tests. You can't really use Wil Test because it's for 2 treatment comparisons.

J
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2019-04-12 21:14
(1837 d 13:26 ago)

@ jag009
Posting: # 20156
Views: 2,450
 

 Going beyond two periods

Hi John & Libaiyi,

❝ Yes there are other tests.


See this extremely old post and Detlew’s reply.

   Reach for the stars,
even if you have to stand on a cactus.
   Susan Longacre

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
UA Flag
Activity
 Admin contact
22,990 posts in 4,826 threads, 1,664 registered users;
63 visitors (1 registered, 62 guests [including 2 identified bots]).
Forum time: 10:41 CEST (Europe/Vienna)

If you don’t like something change it;
if you can’t change it, change the way you think about it.    Mary Engelbreit

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5